Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Alembic Pharmaceuticals Limited ( (IN:APLLTD) ).
Alembic Pharmaceuticals Limited held its 15th Annual General Meeting on August 5, 2025, via video conferencing, adhering to the regulations set by the Companies Act, 2013, and SEBI Listing Regulations, 2015. The meeting, attended by all directors and key auditors, facilitated electronic voting for resolutions and included a statement from the Chairman & CEO, Mr. Chirayu Amin, who addressed company affairs and responded to member inquiries.
More about Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of pharmaceutical products. The company is known for its extensive range of generic formulations and active pharmaceutical ingredients, serving both domestic and international markets.
Average Trading Volume: 29,210
Technical Sentiment Signal: Strong Buy
Current Market Cap: 188.3B INR
See more data about APLLTD stock on TipRanks’ Stock Analysis page.